Correlation Between Arcus Biosciences and Artiva Biotherapeutics,
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on Arcus Biosciences and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Artiva Biotherapeutics,.
Diversification Opportunities for Arcus Biosciences and Artiva Biotherapeutics,
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Arcus and Artiva is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Artiva Biotherapeutics, go up and down completely randomly.
Pair Corralation between Arcus Biosciences and Artiva Biotherapeutics,
Given the investment horizon of 90 days Arcus Biosciences is expected to generate 0.67 times more return on investment than Artiva Biotherapeutics,. However, Arcus Biosciences is 1.5 times less risky than Artiva Biotherapeutics,. It trades about 0.14 of its potential returns per unit of risk. Artiva Biotherapeutics, Common is currently generating about -0.04 per unit of risk. If you would invest 1,456 in Arcus Biosciences on September 25, 2024 and sell it today you would earn a total of 135.00 from holding Arcus Biosciences or generate 9.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arcus Biosciences vs. Artiva Biotherapeutics, Common
Performance |
| Timeline |
| Arcus Biosciences |
| Artiva Biotherapeutics, |
Arcus Biosciences and Artiva Biotherapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcus Biosciences and Artiva Biotherapeutics,
The main advantage of trading using opposite Arcus Biosciences and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.| Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
| Artiva Biotherapeutics, vs. Fate Therapeutics | Artiva Biotherapeutics, vs. Caribou Biosciences | Artiva Biotherapeutics, vs. Karyopharm Therapeutics | Artiva Biotherapeutics, vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stocks Directory Find actively traded stocks across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets |